GlaxoSmithKline appoints Tony Wood as chief scientific officer designate | 19 January 2022
GlaxoSmithKline appoints Tony Wood as chief scientific officer designate
Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GlaxoSmithKline appoints Tony Wood as chief scientific officer designate
/PRNewswire/ -- Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation...
/PRNewswire/ -- Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation...
GlaxoSmithKline appoints Tony Wood as CSO Designate
With $3 billion in capital and an executive team to be led by Hal Barron, MD, until now GlaxoSmithKline (GSK)’s President of R&D and Chief Scientific Officer, Altos Labs™ today emerged from stealth mode, launching as an anti-aging startup with the ambitious aim of reversing disease, injury, and disabilities through cellular rejuvenation programming.